.png)
Summary
Data Protection: Addressing Noise, Speech, and Voice Concerns
Here's our newest conversation with Brij Mohan Lal Srivastava, CEO and Co-founder of Nijta, a company at the forefront of AI in speech anonymization. The realm of voice is an emerging and fascinating area within the life sciences, and with every new domain, issues of privacy come to the forefront.
In this discussion, we converse with Brij Mohan Lal Srivastava, who is the co-founder and CEO of Nijta, a company that focuses on developing AI-powered solutions for data anonymization and pseudonymization. These solutions are becoming increasingly important in clinical research, particularly with the emergence of voice as an important biomarker for identifying diseases such as depression. We delve into the fundamentals of noise, speech, and voice, and also explore how Nijta's technologies can be applied in the life sciences sector.
Sign up for our newsletter
We like to keep our readers up to date on complex regulatory issues, the latest industry trends and updated guidelines to help you to solve a problem or make an informed decision.
Navigating Privacy Requirements for Clinical Trials Across Jurisdictions: Focus on China
China’s data protection regulations play a crucial role in clinical trials, requiring sponsors and researchers to comply with multiple laws, including the PIPL, GCP-2020, and cross-border data transfer rules. Unlike other jurisdictions, China imposes strict consent requirements, risk assessments, and regulatory filings, making compliance a key factor when selecting trial locations and managing participant data.
Addressing the Data Protection and Ethical Challenges posed by AI in Health – Part I
Analyzing the Similarities and Differences Between ICH-GCP and GDPR in Clinical Trials
ICH-GCP and GDPR are vital for clinical trials, setting standards for participant protection and data integrity, with distinct focuses and enforcement approaches.
